Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective: To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design: Randomized clinical trial. (The protocol also included a type 1 diabetes cohort in a parallel trial and subsequent second trial.) (ClinicalTrials.gov: NCT02282397). Setting: 25 endocrinology practices in North America. Patients: 158 adults who had had type 2 diabetes for a median of 17 years (interquartile range, 11 to 23 years). Participants were aged 35 to 79 years (mean, 60 years [SD, 10]), were receiving multiple daily injections of insulin, and had hemoglobin A1c (HbA1c) levels of 7.5% to 9.9% (mean, 8.5%). Intervention: Random assignment to CGM (n = 79) or usual care (control group, n = 79). Measurements: The primary outcome was HbA1c reduction at 24 weeks. Results: Mean HbA1c levels decreased to 7.7% in the CGM group and 8.0% in the control group at 24 weeks (adjusted difference in mean change, -0.3% [95% CI, -0.5% to 0.0%]; P = 0.022). The groups did not differ meaningfully in CGM-measured hypoglycemia or quality-of-life outcomes. The CGM group averaged 6.7 days (SD, 0.9) of CGM use per week. Limitation: 6-month follow-up. Conclusion: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control. Because few insulin-treated patients with type 2 diabetes currently use CGM, these results support an additional management method that may benefit these patients. Primary Funding Source: Dexcom.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Benefits of CGM in this population include reductions in A1C, fewer severe hypoglycemia events in children and adults, increased TIR, as well as significant reductions in hospitalizations for severe hypoglycemia and DKA.156,162–168”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“The clinical efficacy of CGM has been demonstrated in numerous retrospective studies and RCTs of individuals with T1D regardless of insulin delivery method.156–161”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“In addition, CGM use has been reported to reduce fear of hypoglycemia and increase confidence in avoiding/treating hypoglycemia.156,174,175”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“A1C is currently recognized as the key surrogate marker for the development of longterm diabetes complications in people with type 1 and type 2 diabetes and has been used the primary endpoint for many CGM studies (1; 3; 4; 6; 32; 33).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
In the citing paper
“Numerous studies have demonstrated significant clinical benefits of CGM use in people with diabetes regardless of insulin delivery method (1-15).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Self-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 3×
“org), was identical to that of a parallel trial in patients with type 1 diabetes (12), which also had a second phase assessing insulin pump initiation.”
BackgroundResultSelf-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Self-citationClarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Cited by
Items 301–400 of 636
Meng, R., Gu, T., Yang, F., Liu, J., Sun, Q., & Zhu, D. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01171-2 · Cited by 11
Continuous Glucose Monitoring in Pregnancy
Horgan, R., Diab, Y. H., Bartal, M. F., Sibai, B. M., & Saade, G. R. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005374 · Cited by 15
Adıgüzel, G., Şentürk, Ü., & Polat, K. (2024) · Open Journal of Nano · doi:10.56171/ojn.1473276 · Cited by 15
Kim, J. Y., Ilham, S., Alshannaq, H. A., Pollock, R. F., Ahmed, W., Norman, G. J., Jin, S., & Kim, J. H. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2405293 · Cited by 12
UNDERWOOD, P. C., Chirokas, K., Keels, J. N., Vimalananda, V. G., & Magny‐Normilus, C. (2025) · Journal of Health Equity · doi:10.1080/29944694.2024.2444002 · Cited by 12
Maida, E., Caruso, P., Bonavita, S., Abbadessa, G., Miele, G., Longo, M., Scappaticcio, L., Ruocco, E., Trojsi, F., Esposito, K., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124240 · Cited by 22
Management of Diabetic Wounds: Expert Panel Consensus Statement
Hsia, H. C., Eriksson, E. K., Gurtner, G. C., Veves, A., Hamdy, O., Margolis, D. J., Armstrong, D. G., Lavery, L. A., Grice, E., Schultz, G., et al. (2025) · Advances in Wound Care · doi:10.1177/21621918251366586 · Cited by 16
Emerging Landscape of Continuous Glucose Monitoring
Garg, S. K. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0271 · Cited by 10
Management of type 2 diabetes in the new era
Liakos, A., Karagiannis, T., Avgerinos, I., Malandris, K., Τσάπας, Α., & Bekiari, E. (2023) · HORMONES · doi:10.1007/s42000-023-00488-w · Cited by 13
Simonyan, A. R., Isaacs, D. M., Lekic, S., Blanchette, J. E., Noe, D. R., & Galloway, N. R. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1409 · Cited by 12
Virtual visits and the use of continuous glucose monitoring for diabetes care in the era of COVID-19
UNDERWOOD, P. C., Hibben, J., Gibson, J. M., & DiNardo, M. M. (2021) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000659 · Cited by 13
Aleppo, G., Parkin, C. G., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., Umpierrez, G. E., Forlenza, G. P., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0196 · Cited by 11
Self-citationKovatchev, B. P., & Lobo, B. J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0117 · Cited by 10
Lind, N., Christensen, M. B., & Nørgaard, K. (2024) · PEC Innovation · doi:10.1016/j.pecinn.2024.100324 · Cited by 11
Thabit, H., Rubio, J., Karuppan, M., Mubita, W., Lim, J. Z. M., Thomas, T., Fonseca, I., Fullwood, C., Leelarathna, L., & Schofield, J. D. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15885 · Cited by 12
Pai, R., Barua, S., Kim, B. S., McDonald, M., Wierzchowska-McNew, R. A., Pai, A., Deutz, N. E. P., Kerr, D. E., & Sabharwal, A. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241274800 · Cited by 12
Bergenstal, R. M., Martens, T. W., & Beck, R. W. (2025) · JAMA · doi:10.1001/jama.2025.19197 · Cited by 10
Self-citationStrollo, F., Furia, A., Verde, P., Bellia, A., Grussu, M., Mambro, A., Petrelli, M. D., & Gentile, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108638 · Cited by 14
Irace, C., Cutruzzolà, A., Tweden, K. S., & KAUFMAN, F. R. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1982380 · Cited by 14
Telehealth Technologies and Their Benefits to People With Diabetes
Usoh, C. O., Kilen, K., Keyes, C., Johnson, C. P., & Aloi, J. (2022) · Diabetes Spectrum · doi:10.2337/dsi21-0017 · Cited by 10
Nozha, O. M. A., Alshareef, E. K., Aljawi, A. F., Alhabib, E., AlMahweeti, R. S., Aljuhani, S. A., Alamri, S. A., & Alahmadi, O. S. (2022) · Cureus · doi:10.7759/cureus.25038 · Cited by 13
Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?
Wright, E. E., & Subramanian, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0025 · Cited by 11
Health literacy of patients using continuous glucose monitoring
Evans, E. I., Pincus, K. J., Seung, H., & Rochester-Eyeguokan, C. D. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102109 · Cited by 10
Tweden, K. S., Deiss, D., Rastogi, R., Addaguduru, S., & KAUFMAN, F. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0342 · Cited by 12
Pitocco, D., Laurenzi, A., Tomaselli, L. G., Assaloni, R., Consoli, A., Bartolo, P. D., Guardasole, V., Lombardo, F., Maffeis, C., Rossi, A., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.07.003 · Cited by 13
Miller, E., Chuang, J. S., Roberts, G. J., Nabutovsky, Y., Virdi, N., & Wright, E. E. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01619-1 · Cited by 9
Continuous Glucose Monitoring for the Internist
Lee, G. S., & Lupsa, B. C. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.004 · Cited by 13
de Frel, D. L., Schroijen, M. A., Aardoom, J. J., van Gils, W., Huisman, S. D., Janssen, V. R., Versluis, A., Kleinsmann, M. S., Atsma, D. E., & Pijl, H. (2023) · JMIR Human Factors · doi:10.2196/45055 · Cited by 8
Folz, H. N., Lee, S., & Sherrill, C. H. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108578 · Cited by 13
Use of technology in prediabetes and precision prevention
He, J., Chu, N. H. S., Wan, H., Ling, J., Xue, Y., Leung, K. H. T., Yang, A., Shen, J., & Chow, E. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70057 · Cited by 10
Hirani, K., Sundheim, B., Blaschke, M., Lemos, J. R. N., & Mittal, R. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1597128 · Cited by 16
Kotecha, P., Smith, S. M., Donahoo, W. T., DeKosky, S. T., Bian, J., & Guo, J. S. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.41939 · Cited by 12
Advances in Care for Insulin-Requiring Patients Without Closed Loop
Lal, R., Buckingham, B. A., & Maahs, D. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0084 · Cited by 10
Alharbi, M., Albunyan, A., Nahari, A., Azmi, F. A., Alenazi, B., Harbi, T. A., Malki, M. A., & Ahmadi, H. A. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01224-0 · Cited by 10
Lin, Y. K., Agni, A., Chuisano, S. A., Fetters, M. D., Funnell, M. M., Pop‐Busui, R., & DeJonckheere, M. J. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231168859 · Cited by 10
Kong, L., Deng, B., Guo, M., Chen, M., Wang, X., Zhang, M., Tang, H., Wang, Q., Yang, L., & Xiong, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1229494 · Cited by 14
Pangrace, M., Dolan, S., Grace, T., Greene, E., Long, E., McClelland, S., Moore, J., Morgan, D. E., Mullins, H., & Wescott, S. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.1-a.s1 · Cited by 9
Patient-centric care: Unveiling the potential of wearable electronics in clinical practice
Zhao, P., Xu, J., & Han, M. (2024) · Wearable electronics. · doi:10.1016/j.wees.2024.07.001 · Cited by 9
Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story
Hodish, I. (2018) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-018-0056-5 · Cited by 10
Furler, J., O'Neal, D. N., Speight, J., Blackberry, I., Manski-Nankervis, J.-A. E., Thuraisingam, S., Rue, K. D. L., Ginnivan, L., Browne, J. L., Holmes‐Truscott, E., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021435 · Cited by 12
Lind, N., Hansen, D. L., Rasmussen, S. S., & Nørgaard, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-040648 · Cited by 10
Cowart, K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819890865 · Cited by 9
Oikonomidi, T., Ravaud, P., James, A., Cosson, E., Montori, V. M., & Tran, V.-T. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.040 · Cited by 12
Fantasia, K. L., Demers, L., Steenkamp, D., & Modzelewski, K. L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221077132 · Cited by 8
Okuno, T., Macwan, S. A., Miller, D. R., Norman, G. J., Reaven, P. D., & Zhou, J. J. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0083 · Cited by 9
Yoo, J. H., Yang, S. H., Kim, G., & Kim, J. H. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0185 · Cited by 10
Inoue, Y., Kusaka, Y., Shinozaki, K., Lee, I., & Sode, K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070614 · Cited by 8
Salam, M., Bailey, R. J., Calhoun, P. M., McGill, J. B., Bergenstal, R. M., Price, D. A., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0387 · Cited by 9
Self-citationStructured Blood Glucose Monitoring in Primary Care: A Practical, Evidence-Based Approach
Logan, A. D., Jones, J., & Kuritzky, L. (2020) · Clinical Diabetes · doi:10.2337/cd20-0045 · Cited by 9
Hallström, S., Hirsch, I. B., Ekelund, M., Sofizadeh, S., Albrektsson, H., Dahlqvist, S., Svensson, J., & Lind, M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0577 · Cited by 9
Time in range is a tool for assessing the quality of glycemic control in diabetes
Суплотова, Л. А., Сергеевна, С. А., Романова, Н. В., & Shestakova, M. V. (2021) · Diabetes Mellitus · doi:10.14341/dm12703 · Cited by 10
Eldor, R., Roitman, E., Merzon, E., Toledano, Y., Alves, C., & Tsur, A. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.02.004 · Cited by 9
Shields, S. A., Norman, G. J., Thomas, R., & Ciemins, E. L. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231171176 · Cited by 8
North, R. A., Pospisil, C., Clukey, R. J., & Parkin, C. G. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819831071 · Cited by 8
Levy, C. J., Galindo, R. J., Parkin, C. G., Gillis, J., & Argento, N. B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231161317 · Cited by 13
Ko, J., Moon, S., Ajjan, R. A., Lee, M. Y., Lee, H., Choi, B., Park, J., Lee, S., Kang, J., & Park, C. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16304 · Cited by 7
“In the past, CGM has mainly been validated in type 1 diabetes 18,19 and T2D using insulin, 20,21 where insulin titration was the major purpose of using CGM. 24 Evidence supports the potential benefits of CGM as a lifestyle modification tool for pre-diabetes.”
Merino-Torres, J. F., Ilham, S., Alshannaq, H. A., Pollock, R. F., Ahmed, W., & Norman, G. J. (2024) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s483459 · Cited by 8
Ehrhardt, N. M., Montour, L., Berberian, P., Vasconcelos, A. G., Comstock, B. A., & Wright, L. A.-C. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251331526 · Cited by 9
Nishimura, R., Okada, Y., Kuroda, A., Suzuki, J., Hirota, Y., Matsuhisa, M., Ishiguro, M., Ohno, T., Suganuma, Y., Tanaka, K., et al. (2025) · Diabetology International · doi:10.1007/s13340-025-00820-2 · Cited by 9
Hayek, A. A., Klonoff, D. C., Zahrani, W. M. A., Saeed, A. H. A., & Dawish, M. A. A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112458 · Cited by 8
Martens, T. W., Beck, R. W., Griffen, C., Di, J., Elkind-Hirsch, K. E., Johnson, M. L., Castle, J. R., Beck, S. E., & Bergenstal, R. M. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005469 · Cited by 10
Self-citationDrug response in the era of precision medicine: A methodological review
Okyere, D., Bravo-Merodio, L., Xu, Y., Guan, X., Parkhi, D., Gkoutos, G. V., & Acharjee, A. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.11.067 · Cited by 12
Cooper, D. J., Zarabi, S., Farrand, B., Becker, A., & Roslin, M. S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1070187 · Cited by 10
Continuous and Intermittent Glucose Monitoring in 2019
Battelino, T., Dovč, K., & Bode, B. W. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.2501 · Cited by 7
Shi, L., Hellmund, R., & Abbott Diabetes Care, A. (2020) · US Endocrinology · doi:10.17925/use.2020.16.1.24 · Cited by 8
Wu, C. C., Wu, K. C., José, A. S., & Novin, N. (2021) · JMIR Diabetes · doi:10.2196/30626 · Cited by 7
Practical Application of Continuous Glucose Monitoring in Clinical Practice: Case Studies
Unger, J., & Franco, D. R. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0080 · Cited by 7
Defining a Continuous Glucose Baseline to assess the impact of nutritional interventions
Chkroun, C., Trouwborst, I., Cherta-Murillo, A., Owen, L., Darimont, C., & Rytz, A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1203899 · Cited by 10
The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
Kushner, P. R., & Kruger, D. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0093 · Cited by 7
Self-citationGrady, M., Cameron, H., & Katz, L. B. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820949873 · Cited by 7
The Expanding Use of Continuous Glucose Monitoring in Type 2 Diabetes
Dabbagh, Z., McKee, M. D., Pirraglia, P. A., Clements, K. M., Liu, F., Amante, D. J., Shukla, P., & Gerber, B. S. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0536 · Cited by 7
“10,14,51 Social determinants of health, including food insecurity, lack of health insurance, low rates of acculturation, 6 as well as low socioeconomic status, adverse neighborhood environment, and social context, 52 affect diabetes self-management and outcomes.”
Owusu, B., Bivins, B. L., Juste, J., Francis, L., Itambo, J., Akomah, J., Yorukoglu, N., Gbaba, S., Hinneh, T. K., Ajibewa, T. A., et al. (2024) · Journal of Advanced Nursing · doi:10.1111/jan.16277 · Cited by 7
Jensch, H., Setford, S. J., Thomé, N., Srikanthamoorthy, G., Weingärtner, L., Grady, M., Holt, E., & Pfützner, A. (2025) · Sensors · doi:10.3390/s25071985 · Cited by 10
McEwan, P. C., & Evans, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16488 · Cited by 10
Grady, M., Cameron, H., & Holt, E. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01415-3 · Cited by 6
Garden, G. L., Shojaee‐Moradie, F., Hutchison, E. J., Frier, B. M., Shaw, K. M., Heller, S. R., Koehler, G., Mader, J. K., Maher, D., Roberts, G. A., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0069 · Cited by 6
Ajjan, R., Seidu, S., & Riveline, J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01607-5 · Cited by 9
Approach to the Patient Using Diabetes Technology in Pregnancy
Dickens, L. T., & González, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae914 · Cited by 6
Wang, R., Kyi, M., Krishnamoorthi, B., Tjahyadi, J., Connell, A., Chiang, C. Y., Renouf, D., Barmanray, R., & Fourlanos, S. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0604 · Cited by 11
Application of Wearable Devices in Diabetes Management
Du, Z., Zhang, F., Ge, Y., Liu, Y., Yu, H., Wang, Y., Dalan, R., & Shen, X. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100007 · Cited by 6
VIS/NIR/FIR spectroscopy for blood glucose monitoring: A review
Chen, Q., Zhang, W., & Wu, W. (2025) · AIP Advances · doi:10.1063/5.0239187 · Cited by 9
Reiterer, F., Reiter, M., del Re, L., Christensen, M. B., & Nørgaard, K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818770694 · Cited by 7
Endocrine Complications of Cystic Fibrosis: A Multisystem Disease of the Endocrine Organs
Ode, K. L., Chan, C. L., Granandos, A., Putman, M. S., & Moheet, A. A. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1697917 · Cited by 6
Wysham, C., & Kruger, D. F. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab064 · Cited by 7
Self-citationA Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea
Kim, W. J., Kim, J. H., Yoo, H. J., Son, J. W., Khang, A. R., Kwon, S. K., Kim, J. H., Kim, T. H., Ryu, O. H., Park, K. H., et al. (2021) · Journal of Korean Diabetes · doi:10.4093/jkd.2021.22.4.225 · Cited by 7
Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN)
Chao, C., Andrade, S. B., Bergford, S., Calhoun, P. M., Welsh, J. B., Walker, T. C., & ANSHIN Study Group (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.414 · Cited by 6
Lever, C. S., Williman, J. A., Boucsein, A., Watson, A. S., Sampson, R. S., Sergel‐Stringer, O. T., Keesing, C., Chepulis, L. M., Wheeler, B. J., de Bock, M. I., et al. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01244-y · Cited by 6
Maiorino, M. I., Buzzetti, R., Irace, C., Laviola, L., Napoli, N., Pitocco, D., Esposito, K., & on behalf of LIVE CGM working group (2023) · Endocrine · doi:10.1007/s12020-023-03473-w · Cited by 7
Elderly Patients With Diabetes: Special Aspects to Consider
Heinemann, L., Klonoff, D. C., & Kubiak, T. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819833862 · Cited by 7
Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors
Hughes, M. S., Aleppo, G., Bally, L., Batista, A. F. M. B., Brown, S. A., Faulds, E. R., Gonder-Frederick, L. A., Isaacs, D. M., Kahkoska, A. R., Ortega, J., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241296853 · Cited by 6
Self-citationRohner, D. G., Burget, L., Henzen, C., & Fischli, S. (2024) · Swiss Medical Weekly · doi:10.57187/s.3366 · Cited by 6
Yoo, J. H., Moon, S. J., Park, C.-Y., & Kim, J. H. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241262106 · Cited by 11
Huang, X., Jiang, J., Liu, L., Lin, Y., Zhang, F., Ling, X., Wei, H., Huang, G., Ye, J., Huang, C., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14371 · Cited by 6
A low-power approach to optical glucose sensing via polarisation switching
Hassanpour, E., Nasehi, M., Meymandinezhad, A., & Witthauer, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-99367-0 · Cited by 5
Martens, T. W., Johnson, J. L., Katz, M. L., Davidson, M. B., Schneck, K. B., Xue, J., Chang, X., & Dassau, E. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103266 · Cited by 6
A Qualitative Analysis of Provider‐Level Barriers to Prescribing Diabetes Technology
Maizel, J. L., Walker, A. F., Walls, A., Pasquel, F. J., Haller, M. J., & Bruggeman, B. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/8873848 · Cited by 7
Speight, J., Hermanns, N., Jensen, W., Kanc, K., Karagiannis, T., Law, M., Mocan, A., Rutters, F., Sturt, J. A., Zaccardi, F., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06840-0 · Cited by 15
Beltzer, A., Kölle, J., Miró, M. G., Pleus, S., Krauß, C., Haug, C., Safary, E., Vetter, B., & Freckmann, G. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241238146 · Cited by 6
Grace, T., Edgington, A., Reinhart, L., Burkart, T., Dyer, E., Halsey, J., Baroudi, K., Hicks, C., Layne, J. E., & Walker, T. C. (2024) · Clinical Diabetes · doi:10.2337/cd24-0030 · Cited by 7
Yoo, J. H., Jun, J. E., Kwak, S. H., & Kim, J. H. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241306136 · Cited by 7
Metadata
- Authors
- Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., Aronson, R., Toschi, E., Kollman, C., Bergenstal, R., & for the DIAMOND Study Group*
- Affiliations
- Joslin Diabetes Center (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-09-19
- Volume
- 167
- Issue
- 6
- Pages
- 365-374
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2753830550
- Semantic Scholar
- 4f35ac21c54271e1101cc587d928e543765ee06a
- Cited by
- 635
- References
- 31
- Citations by year
- 2026: 58 · 2025: 91 · 2024: 95 · 2023: 77 · 2022: 77 · 2021: 85 · 2020: 43 · 2019: 56 · 2018: 46 · 2017: 6
- FWCI
- 32.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, type 2 diabetes, multiple daily insulin injections, glycemic control, HbA1c reduction, hypoglycemia, quality of life, usual care, type 1 diabetes
- MeSH terms
- Adult, Aged, Bacterial Proteins, Diabetes Mellitus, Type 2, Drug Administration Schedule, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Membrane Proteins, Middle Aged, Quality of Life, Blood Glucose Self-Monitoring, Patient Satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.